ENOS Antikörper (AA 519-690) (Biotin)
Kurzübersicht für ENOS Antikörper (AA 519-690) (Biotin) (ABIN7178986)
Target
Alle ENOS (NOS3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 519-690
-
Verwendungszweck
- Nos3 Antibody, Biotin conjugated
-
Kreuzreaktivität
- Ratte
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant Rat Nitric oxide synthase, endothelial protein (519-690AA)
-
Isotyp
- IgG
-
-
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (pSer1177) antibody
NOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1-120) antibodyNOS3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1105-1202) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), FACS, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (pSer1177) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), FACS, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1156-1183) antibodyNOS3 Reaktivität: Human WB, IF, FACS Wirt: Kaninchen Polyclonal RB29786 unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 48-75), (N-Term) antibodyNOS3 Reaktivität: Human IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB18211 unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (C-Term) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1156-1183) antibodyNOS3 Reaktivität: Human WB, ELISA, IF, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 756-888) antibodyNOS3 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (Thr180), (Tyr182) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
-
Andere Bezeichnung
- Nos3
-
Hintergrund
-
Background: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.
Aliases: Nos3 antibody, Nitric oxide synthase antibody, endothelial antibody, EC 1.14.13.39 antibody, Constitutive NOS antibody, cNOS antibody, EC-NOS antibody, Endothelial NOS antibody, eNOS antibody, NOS type III antibody, NOSIII antibody
-
UniProt
- Q62600
-
Pathways
- ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-
